Form 4: Amgen SVP Rachna Khosla Reports Changes in Beneficial Ownership
SEC Form 4
Rachna Khosla, SVP of Business Development at Amgen, reports a transaction involving common stock related to tax obligations on vested Restricted Stock Units (RSUs).
Summary
- On May 2, 2024, Rachna Khosla, SVP of Business Development at Amgen, reported a transaction involving Amgen's common stock.
- The transaction involved the disposition of 74 shares to cover tax obligations related to vested Restricted Stock Units (RSUs) at a price of $277.37 per share.
- Following the transaction, Khosla directly owns 8,068 shares of Amgen common stock, which includes various RSUs vesting at different dates in the future.
- These RSUs will vest between May 2024 and May 2027.
- The reported holdings also include Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to stock transactions by a company executive. It doesn't indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and their holdings in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 05/02/2024 | Date of transaction: Disposition of 74 shares of common stock. |
| 05/05/2024 | 102 RSUs will vest. |
| 04/30/2025 | 128 RSUs will vest. |
| 11/05/2024 | 386 RSUs will vest. |
| 11/05/2025 | 398 RSUs will vest. |
| 05/02/2025 | 200 RSUs will vest. |
| 05/02/2026 | 207 RSUs will vest. |
| 05/02/2025 | 195 RSUs will vest. |
| 05/02/2026 | 196 RSUs will vest. |
| 05/02/2027 | 202 RSUs will vest. |
| 05/06/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.